{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:19:45Z","timestamp":1787026785801,"version":"build-2736575974"},"reference-count":248,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Impulse control disorders (ICDs), such as excessive gambling, compulsive sexual behavior, binge eating, compulsive shopping as well as punding, and the dopamine dysregulation syndrome, may arise as a debilitating neuropsychiatric complication in Parkinson\u2019s disease (PD). Although the pathophysiology is not fully understood, it likely involves mesolimbic dopaminergic overstimulation combined with disease-related vulnerabilities in reward, motivation, and inhibitory control networks. This narrative review summarizes evidence on the neuropsychological, affective, and behavioral traits associated with ICDs in PD, with a particular focus on epidemiology\/clinical manifestations, neurobiological and pharmacological mechanisms, as well as prevention and management strategies. ICDs can affect up to 40% of PD patients and are strongly associated with dopamine agonist exposure, younger age of onset, premorbid personality traits, and neuropsychiatric comorbidities. Neuropsychological findings reveal abnormalities in several domains, including reflection impulsivity, temporal discounting, novelty seeking, risk processing, and inhibitory control, while mood disorders, sleep dysfunction, apathy, and anxiety further influence vulnerability and worsen behavioral dysregulation. Although general awareness for development of ICDs has been raised, they still represent a significant burden for patients and their family members and are a predictor of functional decline and lower quality of life. Management includes dopamine agonist withdrawal whenever possible, the cessation of fast acting dopaminergic agents and treatment of neuropsychiatric comorbidities. In selected cases, deep brain stimulation or continuous dopaminergic delivery should be considered, particularly in those experiencing persistent worsening of motor symptoms despite appropriate adjustment of dopaminergic medication.<\/jats:p>","DOI":"10.3389\/fnagi.2026.1768251","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:47:37Z","timestamp":1773038857000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuropsychological aspects of impulse control disorders in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Livia","family":"Scanferla","sequence":"first","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atbin","family":"Djamshidian","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/08919887231195219","article-title":"Caregiver burden in Parkinson disease: A scoping review of the literature from 2017-2022.","volume":"37","author":"Aamodt","year":"2024","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/jnnp-2017-316373","article-title":"Subthalamic stimulation and neuropsychiatric symptoms in Parkinson\u2019s disease: Results from a long-term follow-up cohort study.","volume":"89","author":"Abbes","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/jnnp-2013-307214","article-title":"Impulse control behaviours in patients with Parkinson\u2019s disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up.","volume":"86","author":"Amami","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B4","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"B5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/mdc3.13156","article-title":"Reckless generosity, Parkinson\u2019s disease and dopamine: A case series and literature review.","volume":"8","author":"Amstutz","year":"2021","journal-title":"Movement Disord. Clin. Pract."},{"key":"B6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/mdc3.14318","article-title":"Impulse control disorders and effort-based decision-making in Parkinson\u2019s disease patients with subthalamic nucleus deep brain stimulation.","volume":"12","author":"Amstutz","year":"2025","journal-title":"Movement Disord. Clin. Pract."},{"key":"B7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jns.2011.06.006","article-title":"Impulsivity and Parkinson\u2019s disease: More than just disinhibition.","volume":"310","author":"Antonelli","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/00002018-200932060-00004","article-title":"Behavioural adverse effects of dopaminergic treatments in Parkinson\u2019s disease: Incidence, neurobiological basis, management and prevention.","volume":"32","author":"Antonini","year":"2009","journal-title":"Drug Safety"},{"key":"B9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","article-title":"ICARUS study: Prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease.","volume":"88","author":"Antonini","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/mds.23501","article-title":"Impulsivity and compulsivity in drug-na\u00efve patients with Parkinson\u2019s disease.","volume":"26","author":"Antonini","year":"2011","journal-title":"Mov. Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.021","article-title":"Alexithymia in Parkinson\u2019s disease: A systematic review of the literature.","volume":"28","author":"Assogna","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/acn3.51016","article-title":"Self-reported rates of impulsivity in Parkinson\u2019s Disease.","volume":"7","author":"Aumann","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1146\/annurev-clinpsy-032813-153705","article-title":"Impulsive and compulsive behaviors in Parkinson\u2019s disease.","volume":"10","author":"Averbeck","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.nrl.2010.09.007","article-title":"Trastornos del control de los impulsos y punding en la enfermedad de Parkinson: La necesidad de una entrevista estructurada.","volume":"26","author":"\u00c1vila","year":"2011","journal-title":"Neurolog\u00eda"},{"key":"B15","doi-asserted-by":"publisher","first-page":"103315","DOI":"10.1016\/j.nicl.2023.103315","article-title":"Neural correlates of impulse control behaviors in Parkinson\u2019s disease: Analysis of multimodal imaging data.","volume":"37","author":"Baagil","year":"2023","journal-title":"NeuroImage Clin."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1212\/WNL.0000000000007942","article-title":"Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity.","volume":"93","author":"Baig","year":"2019","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0127542","DOI":"10.1371\/journal.pone.0127542","article-title":"Identifying the basal ganglia network model markers for medication-induced impulsivity in Parkinson\u2019s disease patients.","volume":"10","author":"Balasubramani","year":"2015","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease.","volume":"27","author":"Balestrino","year":"2020","journal-title":"Euro. J. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/jnnp-2017-317298","article-title":"Compulsive sexual behaviour in Parkinson\u2019s disease is associated with higher doses of levodopa.","volume":"89","author":"Barbosa","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1590\/0004-282x-anp-2020-0522","article-title":"The prevalence of impulsive compulsive behaviors in patients treated with apomorphine infusion: A retrospective analysis.","volume":"80","author":"Barbosa","year":"2022","journal-title":"Arq. Neuro-Psiquiatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1093\/brain\/awz298","article-title":"Lower nucleus accumbens \u03b1-synuclein load and D3 receptor levels in Parkinson\u2019s disease with impulsive compulsive behaviours.","volume":"142","author":"Barbosa","year":"","journal-title":"Brain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3233\/JPD-181460","article-title":"Saccadic direction errors are associated with impulsive compulsive behaviours in Parkinson\u2019s Disease patients.","volume":"9","author":"Barbosa","year":"","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.25291","article-title":"Prospective cohort study of impulse control disorders in Parkinson\u2019s disease.","volume":"28","author":"Bastiaens","year":"2013","journal-title":"Movement Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ene.12646","article-title":"Impulse control disorders in Parkinson\u2019s disease: Don\u2019t set your mind at rest by self-assessments.","volume":"22","author":"Baumann-Vogel","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s10072-012-1224-5","article-title":"Neuropsychological features of patients with Parkinson\u2019s disease and impulse control disorders.","volume":"34","author":"Bentivoglio","year":"2013","journal-title":"Neurol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42466-019-0013-5","article-title":"Neurobiology and clinical features of impulse control failure in Parkinson\u2019s disease.","volume":"1","author":"B\u00e9reau","year":"2019","journal-title":"Neurol. Res. Pract."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/cells12121599","article-title":"Apathy in Parkinson\u2019s disease: Clinical patterns and neurobiological basis.","volume":"12","author":"B\u00e9reau","year":"2023","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4103\/0028-3886.237019","article-title":"Impulse control disorders in Parkinson\u2019s disease: Review of pathophysiology, epidemiology, clinical features, management, and future challenges.","volume":"66","author":"Bhattacharjee","year":"2018","journal-title":"Neurol India"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/mds.27181","article-title":"Impulse control disorders in advanced Parkinson\u2019s disease with dyskinesia: The ALTHEA study.","volume":"32","author":"Biundo","year":"2017","journal-title":"Mov. Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neurol.2019.07.024","article-title":"Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson\u2019s disease: A large single-center study.","volume":"176","author":"Blaise","year":"2020","journal-title":"Revue Neurologique"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease.","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/brain\/awp094","article-title":"Reward-learning and the novelty-seeking personality: A between- and within-subjects study of the effects of dopamine agonists on young Parkinson\u2019s patients.","volume":"132","author":"Bodi","year":"2009","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.parkreldis.2013.09.006","article-title":"Impulsive and compulsive behaviors among Danish patients with Parkinson\u2019s disease: Prevalence, depression, and personality.","volume":"20","author":"Callesen","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1007\/s00415-021-10724-1","article-title":"Risk factors of impulsive-compulsive behaviors in PD patients: A meta-analysis.","volume":"269","author":"Cao","year":"2022","journal-title":"J. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40263-024-01087-y","article-title":"Impulse control disorders in Parkinson\u2019s disease: An overview of risk factors, pathogenesis and pharmacological management.","volume":"38","author":"Carbone","year":"2024","journal-title":"CNS Drugs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40263-019-00661-z","article-title":"Apomorphine for Parkinson\u2019s disease: Efficacy and safety of current and new formulations.","volume":"33","author":"Carbone","year":"2019","journal-title":"CNS Drugs"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00415-018-8803-1","article-title":"Improvement of impulse control disorders associated with levodopa\u2013carbidopa intestinal gel treatment in advanced Parkinson\u2019s disease.","volume":"265","author":"Catalan","year":"2018","journal-title":"J. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00415-010-5715-0","article-title":"Spectrum of addictions in Parkinson\u2019s disease: From dopamine dysregulation syndrome to impulse control disorders.","volume":"257","author":"Ceravolo","year":"2010","journal-title":"J. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1007\/s00415-021-10443-7","article-title":"Contribution of neuropsychiatric symptoms in Parkinson\u2019s disease to different domains of caregiver burden.","volume":"268","author":"Chahine","year":"2021","journal-title":"J. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jocn.2015.05.059","article-title":"Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson\u2019s disease.","volume":"25","author":"Chang","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons.","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.14802\/jmd.08019","article-title":"Compulsive shopping in Parkinson\u2019s disease - A case report.","volume":"1","author":"Cho","year":"2008","journal-title":"JMD"},{"key":"B43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00429-011-0314-0","article-title":"Impulse control disorders in Parkinson\u2019s disease: Seeking a roadmap toward a better understanding.","volume":"216","author":"Cilia","year":"2011","journal-title":"Brain Struct. Funct."},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pbb.2014.11.017","article-title":"Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.","volume":"129","author":"Claassen","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/mdc3.12155","article-title":"Hypersexuality in Parkinson\u2019s disease: Systematic review and report of 7 new cases.","volume":"2","author":"Codling","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mdc3.12852","article-title":"Serial cats maiming reveals impulse control disorder under dopaminergic agonists.","volume":"7","author":"Cohen","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10072-022-06485-y","article-title":"Screening for impulse control disorders in Parkinson\u2019s disease and dopamine agonist use: A study of pharmacokinetic and psychological risk factors.","volume":"44","author":"Contin","year":"2023","journal-title":"Neurol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.biopsych.2011.03.028","article-title":"Inverted-U\u2013shaped dopamine actions on human working memory and cognitive control.","volume":"69","author":"Cools","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0028-3932(03)00117-9","article-title":"l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson\u2019s disease.","volume":"41","author":"Cools","year":"2003","journal-title":"Neuropsychologia"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease.","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.parkreldis.2017.07.030","article-title":"The rise and fall of impulse control behavior disorders.","volume":"46","author":"Cossu","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5551796","DOI":"10.1155\/2024\/5551796","article-title":"Possible implications of managing alexithymia on quality of life in Parkinson\u2019s disease: A systematic review.","volume":"2024","author":"Culicetto","year":"2024","journal-title":"Parkinson\u2019s Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40519-019-00648-1","article-title":"Compulsive eating behaviors in Parkinson\u2019s disease.","volume":"24","author":"De Chazeron","year":"2019","journal-title":"Eat Weight Disord."},{"key":"B54","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1038\/s41598-021-90266-8","article-title":"A case\u2013control study investigating food addiction in Parkinson patients.","volume":"11","author":"De Chazeron","year":"2021","journal-title":"Sci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mds.29700","article-title":"Management of impulse control and related disorders in Parkinson\u2019s disease: An expert consensus.","volume":"39","author":"Debove","year":"2024","journal-title":"Mov. Disord."},{"key":"B56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10880-012-9302-7","article-title":"Impulse control disorders in Parkinson\u2019s disease: A psychosocial perspective.","volume":"19","author":"Delaney","year":"2012","journal-title":"J. Clin. Psychol. Med. Settings"},{"key":"B57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson\u2019s disease.","volume":"5","author":"Delaville","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/mdc3.70240","article-title":"Subcutaneous apomorphine infusion initiation is associated with impulse control disorder attenuation in advanced Parkinson\u2019s disease patients: Insights from the French NS -park cohort.","volume":"13","author":"Desjardins","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B59","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/ageing\/afj087","article-title":"Sleep-related problems of Parkinson\u2019s disease.","volume":"35","author":"Dhawan","year":"2006","journal-title":"Age Ageing"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1270746","DOI":"10.3389\/fneur.2023.1270746","article-title":"Premature drug reduction after subthalamic nucleus deep brain stimulation leading to worse depression in patients with Parkinson\u2019s disease.","volume":"14","author":"Diao","year":"2023","journal-title":"Front. Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/mds.23821","article-title":"Pathological gambling in Parkinson\u2019s disease\u2014a review of the literature.","volume":"26","author":"Djamshidian","year":"","journal-title":"Mov. Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/mds.23247","article-title":"Risk and learning in impulsive and nonimpulsive patients with Parkinson\u2019s disease.","volume":"25","author":"Djamshidian","year":"2010","journal-title":"Mov. Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JPD-130178","article-title":"Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson\u2019s disease.","volume":"3","author":"Djamshidian","year":"2013","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e32889","DOI":"10.1371\/journal.pone.0032889","article-title":"Effects of dopamine on sensitivity to social bias in Parkinson\u2019s disease.","volume":"7","author":"Djamshidian","year":"","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/mds.25105","article-title":"Decision making, impulsivity, and addictions: Do Parkinson\u2019s disease patients jump to conclusions?","volume":"27","author":"Djamshidian","year":"","journal-title":"Mov. Disord."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.neuropsychologia.2011.04.026","article-title":"Novelty seeking behaviour in Parkinson\u2019s disease.","volume":"49","author":"Djamshidian","year":"","journal-title":"Neuropsychologia"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/970862","article-title":"Impact of impulse control disorders on sleep-wake regulation in Parkinson\u2019s disease.","volume":"2015","author":"Djamshidian","year":"2015","journal-title":"Parkinson\u2019s Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the Global burden of disease study 2016.","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1007\/s12035-024-04400-4","article-title":"Insomnia in Parkinson\u2019s disease: Causes, consequences, and therapeutic approaches.","volume":"62","author":"Duan","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00415-019-09584-7","article-title":"Evolution of impulsive\u2013compulsive behaviors and cognition in Parkinson\u2019s disease.","volume":"267","author":"Erga","year":"2020","journal-title":"J. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.55697\/tnd.2024.109","article-title":"Impulse control disorders related cognitive and behavioral features in Parkinson\u2019s disease.","volume":"30","author":"Erkoc Ataoglu","year":"2024","journal-title":"Turk. J. Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"102822","DOI":"10.1016\/j.nicl.2021.102822","article-title":"Functional correlates of response inhibition in impulse control disorders in Parkinson\u2019s disease.","volume":"32","author":"Esteban-Pe\u00f1alba","year":"2021","journal-title":"NeuroImage Clin."},{"key":"B73","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson\u2019s disease: Its relation to the dopamine dysregulation syndrome.","volume":"19","author":"Evans","year":"2004","journal-title":"Mov. Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.27689","article-title":"Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: Critique and recommendations.","volume":"34","author":"Evans","year":"2019","journal-title":"Mov. Disord."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/mds.22505","article-title":"Impulsive and compulsive behaviors in Parkinson\u2019s disease.","volume":"24","author":"Evans","year":"2009","journal-title":"Mov. Disord."},{"key":"B76","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/PL00005481","article-title":"Varieties of impulsivity.","volume":"146","author":"Evenden","year":"1999","journal-title":"Psychopharmacology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuropsychologia.2016.07.032","article-title":"The Iowa Gambling Task in Parkinson\u2019s disease: A meta-analysis on effects of disease and medication.","volume":"91","author":"Evens","year":"2016","journal-title":"Neuropsychologia"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.sleep.2013.11.037","article-title":"REM sleep behavior disorder is associated to increased risk of impulse control symptoms in patients with Parkinson\u2019s disease.","volume":"14","author":"Fantini","year":"2013","journal-title":"Sleep Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WNN.0b013e31824b4103","article-title":"Comparison of personality characteristics in Parkinson disease patients with and without impulse control disorders and in healthy volunteers.","volume":"25","author":"Farnikova","year":"2012","journal-title":"Cogn. Behav. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(12)70049-2","article-title":"Treatment of motor and non-motor features of Parkinson\u2019s disease with deep brain stimulation.","volume":"11","author":"Fasano","year":"2012","journal-title":"Lancet Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s00415-023-11615-3","article-title":"Levodopa\u2013carbidopa intestinal gel in advanced Parkinson\u2019s disease: Long-term results from COSMOS.","volume":"270","author":"Fasano","year":"2023","journal-title":"J. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: A systematic analysis for the Global burden of disease study 2016.","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11910-018-0875-x","article-title":"Sleep in Parkinson\u2019s disease with impulse control disorder.","volume":"18","author":"Figorilli","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.1146157","article-title":"Hold your horses: Impulsivity, deep brain stimulation, and medication in Parkinsonism.","volume":"318","author":"Frank","year":"2007","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1212\/WNL.0b013e318296e9d5","article-title":"Crack cocaine use due to dopamine agonist therapy in Parkinson disease.","volume":"80","author":"Friedman","year":"2013","journal-title":"Neurology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3233\/JPD-223420","article-title":"Do impulse control disorders impair car driving performance in patients with Parkinson\u2019s disease?","volume":"12","author":"Fr\u00fcndt","year":"2022","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: A multicentre study.","volume":"85","author":"Garcia-Ruiz","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/jnnp.2003.016469","article-title":"Inhibition of ongoing responses in patients with Parkinson\u2019s disease.","volume":"75","author":"Gauggel","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12916-023-02933-4","article-title":"Caregiver burden in Parkinson\u2019s disease: A mixed-methods study.","volume":"21","author":"Geerlings","year":"2023","journal-title":"BMC Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/mdc3.13839","article-title":"Impulsivity traits in Parkinson\u2019s disease: A systematic review and meta-analysis.","volume":"10","author":"Giovannelli","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B91","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies.","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/brain\/awy298","article-title":"Wait and you shall see: Sexual delay discounting in hypersexual Parkinson\u2019s disease.","volume":"142","author":"Girard","year":"2019","journal-title":"Brain"},{"key":"B93","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/mds.25679","article-title":"Alexithymia\u2014An independent risk factor for impulsive-compulsive disorders in Parkinson\u2019s disease.","volume":"29","author":"Goerlich-Dobre","year":"2014","journal-title":"Mov. Disord."},{"key":"B94","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4088\/JCP.v62n1207","article-title":"Demographic and clinical features of 131 adult pathological gamblers.","volume":"62","author":"Grant","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s10072-021-05237-8","article-title":"New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson\u2019s disease.","volume":"42","author":"Grassi","year":"2021","journal-title":"Neurol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s40429-021-00393-5","article-title":"Controversies and clinical recommendations for the treatment of compulsive sexual behavior disorder.","volume":"8","author":"Griffin","year":"2021","journal-title":"Curr. Addict. Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"966525","DOI":"10.3389\/fnagi.2022.966525","article-title":"Exploring brain changes of impulse control disorders in Parkinson\u2019s disease: An ALE study.","volume":"14","author":"Gu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1017\/S1355617715000181","article-title":"Paradoxical effect of dopamine medication on cognition in Parkinson\u2019s disease: Relationship to side of motor onset.","volume":"21","author":"Hanna-Pladdy","year":"2015","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"B99","doi-asserted-by":"publisher","first-page":"120339","DOI":"10.1016\/j.jns.2022.120339","article-title":"The effect of deep brain stimulation on impulse control related disorders in Parkinson\u2019s disease \u2013 A 10-year retrospective study of 137 patients.","volume":"440","author":"Healy","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"17562864251356062","DOI":"10.1177\/17562864251356062","article-title":"Neuropsychiatric disorders in Parkinson\u2019s disease.","volume":"18","author":"Heim","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.2147\/NDT.S213917","article-title":"Impact of non-motor symptoms in Parkinson\u2019s disease: A PMDAlliance survey.","volume":"15","author":"Hermanowicz","year":"2019","journal-title":"NDT"},{"key":"B102","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/mdc3.13738","article-title":"Course of impulse control disorder symptoms in Parkinson\u2019s disease: Deep brain stimulation versus medications.","volume":"10","author":"Hernandez-Con","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1093\/brain\/awae184","article-title":"Subthalamic control of impulsive actions: Insights from deep brain stimulation in Parkinson\u2019s disease.","volume":"147","author":"Herz","year":"2024","journal-title":"Brain"},{"key":"B104","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/acn3.128","article-title":"Dopaminergic therapy affects learning and impulsivity in Parkinson\u2019s disease.","volume":"1","author":"Hiebert","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.11.338","article-title":"Markers of impaired motor and cognitive volition in Parkinson\u2019s disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.","volume":"47","author":"Hinkle","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3389\/fneur.2019.01338","article-title":"Behavioral and neuroanatomical account of impulsivity in Parkinson\u2019s disease.","volume":"10","author":"Hlavat\u00e1","year":"2020","journal-title":"Front. Neurol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/npp.2010.84","article-title":"Intact reward learning but elevated delay discounting in Parkinson\u2019s disease patients with impulsive-compulsive spectrum behaviors.","volume":"35","author":"Housden","year":"2010","journal-title":"Neuropsychopharmacol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/mds.21872","article-title":"The relationship between impulsivity and impulse control disorders in Parkinson\u2019s disease.","volume":"23","author":"Isaias","year":"2008","journal-title":"Mov. Disord."},{"key":"B109","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3233\/JPD-140351","article-title":"Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson\u2019s disease.","volume":"4","author":"Jaakkola","year":"2014","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"16893","DOI":"10.1038\/s41598-020-73756-z","article-title":"Non-motor symptom burden in patients with Parkinson\u2019s disease with impulse control disorders and compulsive behaviours: Results from the COPPADIS cohort.","volume":"10","author":"Jes\u00fas","year":"2020","journal-title":"Sci. Rep."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s11136-022-03321-w","article-title":"Quality of life implications for elevated trait impulsivity in people with Parkinson\u2019s disease.","volume":"32","author":"Jeyadevan","year":"2023","journal-title":"Qual. Life Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/mdc3.13824","article-title":"Predictors of burden in carers of patients with impulse control behaviors in Parkinson\u2019s disease.","volume":"10","author":"Johnson","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B113","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.parkreldis.2011.09.007","article-title":"Impulse control disorders and depression in Finnish patients with Parkinson\u2019s disease.","volume":"18","author":"Joutsa","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"B114","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease.","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/healthcare13151850","article-title":"The cognitive cost of motor control: A systematic review and meta-analysis of Parkinson\u2019s disease treatments and financial decision-making.","volume":"13","author":"Kandylaki","year":"2025","journal-title":"Healthcare"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3390\/medicina59111942","article-title":"Frequency of impulsive-compulsive behavior and associated psychological factors in Parkinson\u2019s disease: Lack of control or too much of it?","volume":"59","author":"Kapsomenakis","year":"2023","journal-title":"Medicina"},{"key":"B117","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jns.2017.01.019","article-title":"Management of impulse control disorders with deep brain stimulation: A double-edged sword.","volume":"374","author":"Kasemsuk","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/jnnp-2019-322453","article-title":"Spectrum of impulse control behaviours in Parkinson\u2019s disease: Pathophysiology and management.","volume":"91","author":"Kelly","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.parkreldis.2014.03.022","article-title":"REM sleep behavior disorder: Association with motor complications and impulse control disorders in Parkinson\u2019s disease.","volume":"20","author":"Kim","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"B120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3758\/s13415-018-00646-3","article-title":"Dopaminergic influences on risk preferences of Parkinson\u2019s disease patients.","volume":"19","author":"Kobayashi","year":"2019","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s12325-017-0571-2","article-title":"An observational study of the effect of levodopa\u2013carbidopa intestinal gel on activities of daily living and quality of life in advanced Parkinson\u2019s disease patients.","volume":"34","author":"Kr\u00fcger","year":"2017","journal-title":"Adv. Ther."},{"key":"B122","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jns.2019.01.034","article-title":"Impulse control disorders in Parkinson\u2019s disease: A systematic review on risk factors and pathophysiology.","volume":"398","author":"Latella","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14802\/jmd.14010","article-title":"Maladaptive reward-learning and impulse control disorders in patients with Parkinson\u2019s disease: A clinical overview and pathophysiology update.","volume":"7","author":"Lee","year":"2014","journal-title":"JMD"},{"key":"B124","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/jnnp-2018-318942","article-title":"Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: Results of REIN-PD trial.","volume":"90","author":"Lee","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B125","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/nmt.12.35","article-title":"Impulse control disorders in Parkinson\u2019s disease: Background and update on prevention and management.","volume":"2","author":"Leeman","year":"2012","journal-title":"Neurodegen. Dis. Manage."},{"key":"B126","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00702-023-02588-8","article-title":"Characteristics of behavioural addiction in Parkinson\u2019s disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: A matched case\u2013control study.","volume":"130","author":"Leplow","year":"2023","journal-title":"J. Neural Transm."},{"key":"B127","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00702-016-1648-9","article-title":"Impaired learning of punishments in Parkinson\u2019s disease with and without impulse control disorder.","volume":"124","author":"Leplow","year":"2017","journal-title":"J. Neural Transm."},{"key":"B128","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/jnp.12026","article-title":"Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson\u2019s disease.","volume":"7","author":"Leroi","year":"2013","journal-title":"J. Neuropsychol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/brain\/aws078","article-title":"Subthalamic stimulation in Parkinson\u2019s disease: Restoring the balance of motivated behaviours.","volume":"135","author":"Lhomm\u00e9e","year":"2012","journal-title":"Brain"},{"key":"B130","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1474-4422(18)30035-8","article-title":"Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson\u2019s disease with early motor complications (EARLYSTIM trial): Secondary analysis of an open-label randomised trial.","volume":"17","author":"Lhomm\u00e9e","year":"2018","journal-title":"Lancet Neurol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1007\/s10072-023-06956-w","article-title":"Predictors of dopamine dysregulation syndrome in patients with early Parkinson\u2019s disease.","volume":"44","author":"Liang","year":"2023","journal-title":"Neurol Sci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1038\/s41598-024-53076-2","article-title":"Subjective feelings associated with expectations and rewards during risky decision-making in impulse control disorder.","volume":"14","author":"Liebenow","year":"2024","journal-title":"Sci. Rep."},{"key":"B133","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1196\/annals.1444.006","article-title":"Impulse control and related disorders in Parkinson\u2019s disease: Review.","volume":"1142","author":"Lim","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1007\/s00415-019-09337-6","article-title":"Motor and non-motor outcomes in patients with advanced Parkinson\u2019s disease treated with levodopa\/carbidopa intestinal gel: Final results of the GREENFIELD observational study.","volume":"266","author":"Lopiano","year":"2019","journal-title":"J. Neurol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/572743","article-title":"Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson\u2019s disease: Implications for cognitive function.","volume":"2011","author":"MacDonald","year":"2011","journal-title":"Parkinson\u2019s Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1007\/s00415-024-12233-3","article-title":"Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson\u2019s disease.","volume":"271","author":"Maggi","year":"2024","journal-title":"J. Neurol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-017-0024-2","article-title":"Response inhibition in Parkinson\u2019s disease: A meta-analysis of dopaminergic medication and disease duration effects.","volume":"3","author":"Manza","year":"2017","journal-title":"npj Parkinson\u2019s Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.25581","article-title":"Depression as a risk factor for impulse control disorders in Parkinson disease.","volume":"86","author":"Mar\u00edn-Lahoz","year":"2019","journal-title":"Ann. Neurol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00415-019-09692-4","article-title":"Dynamics of impulsive\u2013compulsive behaviors in early Parkinson\u2019s disease: A prospective study.","volume":"267","author":"Markovi\u0107","year":"2020","journal-title":"J. Neurol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00415-024-12865-5","article-title":"Impulse control disorders in Parkinson\u2019s disease: What\u2019s new?","volume":"272","author":"Marques","year":"2025","journal-title":"J. Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00702-018-1870-8","article-title":"Impulse control disorders in Parkinson\u2019s disease.","volume":"125","author":"Marques","year":"2018","journal-title":"J. Neural Transm."},{"key":"B142","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fneur.2019.00266","article-title":"Impact of cognitive profile on impulse control disorders presence and severity in Parkinson\u2019s disease.","volume":"10","author":"Martini","year":"2019","journal-title":"Front. Neurol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2110958","DOI":"10.1016\/j.clinph.2025.2110958","article-title":"EEG changes induced by dopamine replacement therapy in Parkinson\u2019s disease with impulse control disorders.","volume":"178","author":"Mart\u00edn-Rodr\u00edguez","year":"2025","journal-title":"Clin. Neurophysiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3233\/JPD-213070","article-title":"Early Parkinson\u2019s disease phenotypes tailored by personality, behavior, and motor symptoms.","volume":"12","author":"Meira","year":"2022","journal-title":"JPD"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1111\/cns.14173","article-title":"Longitudinal cognitive changes in patients with early Parkinson\u2019s disease and neuropsychiatric symptoms.","volume":"29","author":"Meng","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"B146","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00415-016-8314-x","article-title":"Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.","volume":"264","author":"Merola","year":"2017","journal-title":"J. Neurol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1756285613476127","article-title":"Diagnosis and treatment of impulse control disorders in patients with movement disorders.","volume":"6","author":"Mestre","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B148","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/WNF.0000000000000074","article-title":"Pet killing as a manifestation of impulse control disorder secondary to pramipexol.","volume":"38","author":"Micheli","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/mds.23756","article-title":"Intertemporal choice in Parkinson\u2019s disease.","volume":"26","author":"Milenkova","year":"2011","journal-title":"Mov. Disord."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/mds.21296","article-title":"Punding prevalence in Parkinson\u2019s disease.","volume":"22","author":"Miyasaki","year":"2007","journal-title":"Mov. Disord."},{"key":"B151","doi-asserted-by":"publisher","first-page":"105918","DOI":"10.1016\/j.parkreldis.2023.105918","article-title":"Examining the link between impulse control disorder and antidepressant use in Parkinson\u2019s disease.","volume":"117","author":"Morrow","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"B152","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0891988717720302","article-title":"Caregiver burden in Parkinson disease: A critical review of recent literature.","volume":"30","author":"Mosley","year":"2017","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: A unified framework.","volume":"68","author":"Moustafa","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B154","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mds.26068","article-title":"Linking neuroscience with modern concepts of impulse control disorders in Parkinson\u2019s disease.","volume":"30","author":"Napier","year":"2015","journal-title":"Mov. Disord."},{"key":"B155","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/02698811221144636","article-title":"Role of serotonin in modulation of decision-making in Parkinson\u2019s disease.","volume":"37","author":"Nobis","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/mds.23016","article-title":"Excessive hoarding in Parkinson\u2019s disease.","volume":"25","author":"O\u2019Sullivan","year":"","journal-title":"Mov. Disord."},{"key":"B157","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/jnnp.2007.129015","article-title":"Punding in Parkinson\u2019s disease.","volume":"7","author":"O\u2019Sullivan","year":"2007","journal-title":"Pract. Neurol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mds.22687","article-title":"Reckless generosity in Parkinson\u2019s disease.","volume":"25","author":"O\u2019Sullivan","year":"","journal-title":"Mov. Disord."},{"key":"B159","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours.","volume":"134","author":"O\u2019Sullivan","year":"2011","journal-title":"Brain"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/j.1468-1331.2011.03432.x","article-title":"Impulse control disorders and dopamine dysregulation in Parkinson\u2019s disease: A broader conceptual framework: Impulse control disorder in Parkinson\u2019s disease.","volume":"18","author":"Okai","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","article-title":"Dopamine dysregulation syndrome: An overview of its epidemiology, mechanisms and management.","volume":"23","author":"O\u2019Sullivan","year":"2009","journal-title":"CNS Drugs"},{"key":"B162","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jare.2017.09.004","article-title":"Impulse control disorder and response-inhibition alterations in Parkinson\u2019s disease. A rare case of totally absent functionality of the medial-prefrontal cortex and review of literature.","volume":"8","author":"Palermo","year":"2017","journal-title":"J. Adv. Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/WNL.0000000000000729","article-title":"Naltrexone for impulse control disorders in Parkinson disease: A placebo-controlled study.","volume":"83","author":"Papay","year":"2014","journal-title":"Neurology"},{"key":"B164","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mdc3.13128","article-title":"Does the country make a difference in impulse control disorders? A systematic review.","volume":"8","author":"Parra-D\u00edaz","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B165","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/ijtm4040042","article-title":"Novelty seeking in Parkinson\u2019s disease: A candidate biomarker for cognitive changes.","volume":"4","author":"Paulk","year":"2024","journal-title":"IJTM"},{"key":"B166","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2013.02.032","article-title":"Effect of impulse control disorders on disability and quality of life in Parkinson\u2019s disease patients.","volume":"21","author":"Phu","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00702-016-1549-y","article-title":"Executive functioning and risk-taking behavior in Parkinson\u2019s disease patients with impulse control disorders.","volume":"123","author":"Pineau","year":"2016","journal-title":"J Neural Transm"},{"key":"B168","doi-asserted-by":"publisher","first-page":"7814","DOI":"10.1523\/JNEUROSCI.4063-13.2014","article-title":"Impulse control disorders in Parkinson\u2019s disease are associated with dysfunction in stimulus valuation but not action valuation.","volume":"34","author":"Piray","year":"2014","journal-title":"J. Neurosci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/2045125312470130","article-title":"Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson\u2019s disease: A review.","volume":"3","author":"Poletti","year":"2013","journal-title":"Therapeutic Adv. Psychopharmacol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-021-00167-w","article-title":"Human moral decision-making through the lens of Parkinson\u2019s disease.","volume":"7","author":"Ponsi","year":"2021","journal-title":"npj Parkinsons Dis."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","article-title":"Clinical features associated with impulse control disorders in Parkinson disease.","volume":"67","author":"Pontone","year":"2006","journal-title":"Neurology"},{"key":"B172","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tics.2014.03.007","article-title":"The neural bases of cognitive processes in gambling disorder.","volume":"18","author":"Potenza","year":"2014","journal-title":"Trends Cogn. Sci."},{"key":"B173","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","article-title":"Depression in patients with Parkinson\u2019s disease: Current understanding of its neurobiology and implications for treatment.","volume":"39","author":"Prange","year":"2022","journal-title":"Drugs Aging"},{"key":"B174","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1093\/brain\/awaf087","article-title":"Serotonergic dysfunction in patients with impulse control disorders in Parkinson\u2019s disease.","volume":"148","author":"Prange","year":"2025","journal-title":"Brain"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/mdc3.13748","article-title":"Punding in Parkinson\u2019s disease: An update.","volume":"10","author":"Rajalingam","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B176","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: A review of the literature.","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMSN"},{"key":"B177","doi-asserted-by":"publisher","first-page":"101361","DOI":"10.1016\/j.inat.2021.101361","article-title":"Effect of deep brain stimulation on impulse control behaviors of Parkinson\u2019s disease patients: A systematic review and meta-analysis.","volume":"26","author":"Razmkon","year":"2021","journal-title":"Interdisciplinary Neurosurg."},{"key":"B178","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2019.02.042","article-title":"Current treatment of behavioral and cognitive symptoms of Parkinson\u2019s disease.","volume":"59","author":"Rektorova","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1257618","DOI":"10.3389\/fnagi.2023.1257618","article-title":"Evaluation of risk factors for impulse control disorder in Parkinson\u2019s disease in northern China.","volume":"15","author":"Ren","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"B180","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/JPD-150747","article-title":"Impact of mood and behavioral disorders on quality of life in Parkinson\u2019s disease.","volume":"6","author":"Rieu","year":"2016","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/ene.13034","article-title":"A European multicentre survey of impulse control behaviours in Parkinson\u2019s disease patients treated with short- and long-acting dopamine agonists.","volume":"23","author":"Rizos","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/mds.22836","article-title":"Cognitive impulsivity in Parkinson\u2019s disease patients: Assessment and pathophysiology.","volume":"24","author":"Robert","year":"2009","journal-title":"Mov. Disord."},{"key":"B183","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-psych-011624-024031","article-title":"The incentive-sensitization theory of addiction 30 years on.","volume":"76","author":"Robinson","year":"2025","journal-title":"Annu. Rev. Psychol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/npp.2010.165","article-title":"The roles of dopamine and serotonin in decision making: Evidence from pharmacological experiments in humans.","volume":"36","author":"Rogers","year":"2011","journal-title":"Neuropsychopharmacol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mds.22939","article-title":"An exploration of the burden experienced by spousal caregivers of individuals with Parkinson\u2019s disease.","volume":"25","author":"Roland","year":"2010","journal-title":"Mov. Disord."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/mds.10265","article-title":"Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson\u2019s disease.","volume":"17","author":"Romito","year":"2002","journal-title":"Mov. Disord."},{"key":"B187","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mdc3.12592","article-title":"Challenges in PD patient management after DBS: A pragmatic review.","volume":"5","author":"Rossi","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B188","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1468-1331.2009.02792.x","article-title":"Decision-making in Parkinson\u2019s disease patients with and without pathological gambling.","volume":"17","author":"Rossi","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s00221-022-06423-6","article-title":"Neural correlates of risky decision making in Parkinson\u2019s disease patients with impulse control disorders.","volume":"240","author":"Ruitenberg","year":"2022","journal-title":"Exp. Brain Res."},{"key":"B190","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fneur.2018.00279","article-title":"Impulsivity in Parkinson\u2019s disease is associated with alterations in affective and sensorimotor striatal networks.","volume":"9","author":"Ruitenberg","year":"2018","journal-title":"Front. Neurol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"15104","DOI":"10.1523\/JNEUROSCI.3524-09.2009","article-title":"Dopaminergic drugs modulate learning rates and perseveration in Parkinson\u2019s patients in a dynamic foraging task.","volume":"29","author":"Rutledge","year":"2009","journal-title":"J. Neurosci."},{"key":"B192","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.parkreldis.2013.02.007","article-title":"Pathological gambling in Parkinson\u2019s disease. A comprehensive review.","volume":"19","author":"Santangelo","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"B193","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neubiorev.2017.02.018","article-title":"The relationship between Impulse Control Disorders and cognitive dysfunctions in Parkinson\u2019s Disease: A meta-analysis.","volume":"77","author":"Santangelo","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B194","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13760-018-0986-9","article-title":"The moral brain and moral behaviour in patients with Parkinson\u2019s disease: A review of the literature.","volume":"118","author":"Santens","year":"2018","journal-title":"Acta Neurol. Belg."},{"key":"B195","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mds.28320","article-title":"Impact of subthalamic deep brain stimulation on impulse control disorders in Parkinson\u2019s disease: A prospective study.","volume":"36","author":"Santin","year":"2021","journal-title":"Mov. Disord."},{"key":"B196","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/0891988720964250","article-title":"Sleep problems are related to a worse quality of life and a greater non-motor symptoms burden in Parkinson\u2019s disease.","volume":"34","author":"Santos-Garc\u00eda","year":"2021","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnbeh.2020.00047","article-title":"Impulsivity and compulsivity after subthalamic deep brain stimulation for Parkinson\u2019s disease.","volume":"14","author":"Scherrer","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"B198","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.parkreldis.2013.06.018","article-title":"Sleep and impulsivity in Parkinson\u2019s disease.","volume":"19","author":"Scullin","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"B199","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/syn.21805","article-title":"Parkinson\u2019s disease treatment may cause impulse-control disorder via dopamine D3 receptors: Impulse-control disorder and D3 receptors.","volume":"69","author":"Seeman","year":"2015","journal-title":"Synapse"},{"key":"B200","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.parkreldis.2011.08.016","article-title":"Relationships between deep brain stimulation and impulse control disorders in Parkinson\u2019s disease, with a literature review.","volume":"18","author":"Shotbolt","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"B201","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/mds.26160","article-title":"Long-term cognitive follow-up of Parkinson\u2019s disease patients with impulse control disorders.","volume":"30","author":"Siri","year":"2015","journal-title":"Mov. Disord."},{"key":"B202","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-022-00287-x","article-title":"The emerging postural instability phenotype in idiopathic Parkinson disease.","volume":"8","author":"Skidmore","year":"2022","journal-title":"npj Parkinsons Dis."},{"key":"B203","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/mds.23508","article-title":"The prevalence and clinical characteristics of punding in Parkinson\u2019s disease.","volume":"26","author":"Spencer","year":"2011","journal-title":"Mov. Disord."},{"key":"B204","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3410\/M1-29","article-title":"Impulse control disorders in Parkinson\u2019s disease.","volume":"1","author":"Stacy","year":"2009","journal-title":"F1000 Med. Rep."},{"key":"B205","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/NRL.0b013e31816606a7","article-title":"Impulse control disorders and pathological gambling in patients with Parkinson disease.","volume":"14","author":"Stamey","year":"2008","journal-title":"Neurologist"},{"key":"B206","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s43163-021-00125-6","article-title":"Assessment of postural instability in Parkinson\u2019s disease patients.","volume":"37","author":"Talaat","year":"2021","journal-title":"Egypt J. Otolaryngol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.2147\/NDT.S485339","article-title":"Excessive daytime sleepiness as a risk factor for impulse control disorders in Parkinson\u2019s disease.","volume":"20","author":"Tang","year":"2024","journal-title":"NDT"},{"key":"B208","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.1038\/s41598-024-79966-z","article-title":"A qualitative study exploring the clinical phenomenology and impact of hypersexuality in patients with Parkinson\u2019s Disease.","volume":"14","author":"Tayim","year":"2024","journal-title":"Sci. Rep."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00415-021-10733-0","article-title":"Effects of tDCS on reward responsiveness and valuation in Parkinson\u2019s patients with impulse control disorders.","volume":"269","author":"Terenzi","year":"2022","journal-title":"J. Neurol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1007\/s10072-025-08151-5","article-title":"Impulse control and related behavioral disorders in Parkinson\u2019s disease. Risk factors, diagnosis, and management. Is there a possible role for non-invasive brain stimulation?","volume":"46","author":"Terruzzi","year":"2025","journal-title":"Neurol. Sci"},{"key":"B211","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/WNF.0000000000000091","article-title":"Infusion therapies and development of impulse control disorders in advanced Parkinson disease: Clinical experience after 3 years\u2019 follow-up.","volume":"38","author":"Todorova","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"102362","DOI":"10.1016\/j.nicl.2020.102362","article-title":"Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson\u2019s disease.","volume":"28","author":"Van Der Vegt","year":"2020","journal-title":"NeuroImage Clin."},{"key":"B213","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1038\/npp.2009.124","article-title":"Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: A trigger for pathological gambling in Parkinson\u2019s disease?","volume":"34","author":"Van Eimeren","year":"2009","journal-title":"Neuropsychopharmacol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","article-title":"The high prevalence of impulse control behaviors in patients with early-onset Parkinson\u2019s disease: A cross-sectional multicenter study.","volume":"368","author":"Vela","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/S1353-8020(11)70026-8","article-title":"Impulse control disorders in Parkinson\u2019s disease.","volume":"18","author":"Vilas","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"B216","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/14737175.2019.1620603","article-title":"Parkinson\u2019s disease management and impulse control disorders: Current state and future perspectives.","volume":"19","author":"Vitale","year":"2019","journal-title":"Expert Rev. Neurotherapeutics"},{"key":"B217","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/B978-0-12-805308-9.00024-5","article-title":"Decision-making and impulse control disorders in Parkinson\u2019s disease","volume-title":"Decision Neuroscience","author":"Voon","year":"2017"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s44220-024-00289-z","article-title":"Modeling impulsivity and risk aversion in the subthalamic nucleus with deep brain stimulation.","volume":"2","author":"Voon","year":"2024","journal-title":"Nat. Mental Health"},{"key":"B219","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","article-title":"Impulse control disorders in Parkinson\u2019s disease: Recent advances.","volume":"24","author":"Voon","year":"","journal-title":"Curr. Opin. Neurol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","article-title":"Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: An update.","volume":"16","author":"Voon","year":"2017","journal-title":"Lancet Neurol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00213-009-1697-y","article-title":"Impulsive choice and response in dopamine agonist-related impulse control behaviors.","volume":"207","author":"Voon","year":"2010","journal-title":"Psychopharmacology"},{"key":"B222","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in parkinson disease: A multicenter case\u2013control study.","volume":"69","author":"Voon","year":"","journal-title":"Ann. Neurol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/archneur.64.2.212","article-title":"Factors associated with dopaminergic drug\u2013related pathological gambling in Parkinson disease.","volume":"64","author":"Voon","year":"2007","journal-title":"Arch. Neurol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00441-017-2771-0","article-title":"The neurobiology of impulse control disorders in Parkinson\u2019s disease: From neurotransmitters to neural networks.","volume":"373","author":"Vriend","year":"2018","journal-title":"Cell Tissue Res."},{"key":"B225","doi-asserted-by":"publisher","first-page":"106026","DOI":"10.1016\/j.neubiorev.2025.106026","article-title":"Impulse control in Parkinson\u2019s disease: Distinct effects between action and choice.","volume":"169","author":"Warden","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/jnnp-2017-315985","article-title":"Dopamine dysregulation syndrome in Parkinson\u2019s disease: A systematic review of published cases.","volume":"88","author":"Warren","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B227","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3233\/JPD-212959","article-title":"Trait anxiety as a risk factor for impulse control disorders in de novo Parkinson\u2019s disease.","volume":"12","author":"Waskowiak","year":"2022","journal-title":"JPD"},{"key":"B228","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson\u2019s disease: Advances and challenges.","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1176\/appi.ajp.2018.18040465","article-title":"Impulse control disorders in Parkinson\u2019s disease.","volume":"176","author":"Weintraub","year":"2019","journal-title":"AJP"},{"key":"B230","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson\u2019s disease.","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov. Disord."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease.","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov. Disord."},{"key":"B232","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients.","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease\u2013rating scale.","volume":"27","author":"Weintraub","year":"2012","journal-title":"Mov. Disord."},{"key":"B234","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: A case-control study.","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"key":"B235","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1212\/CPJ.0b013e318278be9b","article-title":"Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease.","volume":"2","author":"Weiss","year":"2012","journal-title":"Neurol. Clin. Pract."},{"key":"B236","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/jnp.12415","article-title":"Dopamine genetic risk scores and psychiatric symptoms: Interacting risk factors for impulse control behaviours in de novo Parkinson\u2019s disease.","volume":"19","author":"Whooley","year":"2025","journal-title":"J. Neuropsychol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s40263-016-0336-5","article-title":"Levodopa\u2013carbidopa intestinal gel in patients with Parkinson\u2019s disease: A systematic review.","volume":"30","author":"Wirdefeldt","year":"2016","journal-title":"CNS Drugs"},{"key":"B238","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1007\/s00415-023-12170-7","article-title":"Prognosis of impulse control disorders in Parkinson\u2019s disease: A prospective controlled study.","volume":"271","author":"Wirth","year":"2024","journal-title":"J. Neurol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jnnp-2024-334116","article-title":"Impulse control disorders in Parkinson\u2019s disease: A national Swedish registry study on high-risk treatments and vulnerable patient groups.","volume":"96","author":"Wolfschlag","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B240","volume-title":"International Classification of Diseases 11th Revision (ICD-11).","year":"2022"},{"key":"B241","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/157340012800792993","article-title":"Impulse control disorders in Parkinson\u2019s disease: A review.","volume":"8","author":"Wu","year":"2012","journal-title":"CPSR"},{"key":"B242","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-015-7722-7","article-title":"Single versus multiple impulse control disorders in Parkinson\u2019s disease: An 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.","volume":"262","author":"Wu","year":"2015","journal-title":"J. Neurol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1162\/jocn_a_00241","article-title":"Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease.","volume":"24","author":"Wylie","year":"2012","journal-title":"J. Cogn. Neurosci."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1565046","DOI":"10.3389\/fneur.2025.1565046","article-title":"The impact of impulse control disorders on cognitive decline in de novo Parkinson\u2019s disease: A study based on structural MRI.","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Neurol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000536555","article-title":"Associations between sleep disorders and impulsive-compulsive behaviors in Parkinson\u2019s disease: A prospective cohort study.","volume":"58","author":"Ye","year":"2024","journal-title":"Neuroepidemiology"},{"key":"B246","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.biopsych.2014.01.024","article-title":"Improving response inhibition in Parkinson\u2019s disease with atomoxetine.","volume":"77","author":"Ye","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B247","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1176\/jnp.23.1.jnp56","article-title":"Binge eating in Parkinson\u2019s disease: Prevalence, correlates and the contribution of deep brain stimulation.","volume":"23","author":"Zahodne","year":"2011","journal-title":"JNP"},{"key":"B248","doi-asserted-by":"publisher","first-page":"1275170","DOI":"10.3389\/fneur.2023.1275170","article-title":"Assessing impulse control behaviors in early Parkinson\u2019s disease: A longitudinal study.","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Neurol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1768251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:47:40Z","timestamp":1773038860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1768251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":248,"alternative-id":["10.3389\/fnagi.2026.1768251"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1768251","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"article-number":"1768251"}}